Text Size

Management of inflammation in dry eye disease: Recommendations from a European panel of experts

Messmer EM, Ahmad S, Benitez del Castillo JM, Mrukwa-Kominek E, Rolando M, Vitovska O, Baudouin C, On behalf of a panel of European Dry Eye Disease experts

  • 2022
  • European Journal of Ophthalmology
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Disease understanding (epidemiology, diagnosis, QoL, Biomarkers…)

  • Affiliations

    Department of Ophthalmology, Ludwig Maximilian University, Munich, Germany; 4960Moorfields Eye Hospital NHS Foundation Trust, London, UK; Hospital Clínico San Carlos, Complutense University of Madrid, Clínica Rementería, Madrid, Spain; Department of Ophthalmology, 49613Medical University of Silesia, Katowice, Poland; Department of Ophthalmology, 9302University of Genoa, Genoa, Italy; National Medical University 'O.O. Bogomolec', Kiev, Ukraine; Department of Ophthalmology, Quinze-Vingts National Ophthalmology Hospital and Vision Institute, Paris, France.

Related Publications

Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.

Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease

Labetoulle M, Garhöfer G, Ismail D, Garrigue JS, Amrane M, Guillon M, Aragona P, Baudouin C.

Epinastine Cream: A Novel Once-Daily Therapeutic Agent for Allergic Conjunctivitis

Ogura N., Fujisawa K., Kato M.

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022